Screening for human ADME/Tox drug properties in drug discovery (Q34194499)

31 July 2017

title

Screening for human ADME/Tox drug properties in drug discovery (English)

1 reference

31 July 2017

0 references

1 reference

A P. Li

1 reference

31 July 2017

publication date

1 April 2001

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

357-366

1 reference

Success rates for new drugs entering clinical testing in the United States

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivudine with 5-fluorouracil prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

The human hepatic cytochromes P450 involved in drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Optimization of cryopreservation procedures for rat and human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 Gilson liquid handler

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Overview: pharmacokinetic drug-drug interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Fluorometric high-throughput screening for inhibitors of cytochrome P450

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Use of the nuclear receptor PXR to predict drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

Ethionine toxicity in vitro: the correlation of data from rat hepatocyte suspensions and monolayers with in vivo observations

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

A fluorometric method for determination of oxidized and reduced glutathione in tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2801%2901712-3

7 January 2021

10.1016/S1359-6446(01)01712-3

Identifiers

DOI

1 reference

31 July 2017

1 reference